These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31018065)

  • 1. A Temporizing Solution to "Artemisinin Resistance".
    Wang J; Xu C; Liao FL; Jiang T; Krishna S; Tu Y
    N Engl J Med; 2019 May; 380(22):2087-2089. PubMed ID: 31018065
    [No Abstract]   [Full Text] [Related]  

  • 2. Artemisinin resistance, some facts and opinions.
    Pantaleo A; Pau MC; Chien HD; Turrini F
    J Infect Dev Ctries; 2015 Jul; 9(6):597-9. PubMed ID: 26142668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 4. Malaria. Signs of drug resistance rattle experts, trigger bold plan.
    Enserink M
    Science; 2008 Dec; 322(5909):1776. PubMed ID: 19095911
    [No Abstract]   [Full Text] [Related]  

  • 5. Curcumin-artemisinin combination therapy for malaria.
    Nandakumar DN; Nagaraj VA; Vathsala PG; Rangarajan P; Padmanaban G
    Antimicrob Agents Chemother; 2006 May; 50(5):1859-60. PubMed ID: 16641461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug development: Holding out for reinforcements.
    Eisenstein M
    Nature; 2012 Apr; 484(7395):S16-8. PubMed ID: 22534526
    [No Abstract]   [Full Text] [Related]  

  • 7. Artemisinin Bioactivity and Resistance in Malaria Parasites.
    Talman AM; Clain J; Duval R; Ménard R; Ariey F
    Trends Parasitol; 2019 Dec; 35(12):953-963. PubMed ID: 31699532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinins: activities and actions.
    Haynes RK; Krishna S
    Microbes Infect; 2004 Nov; 6(14):1339-46. PubMed ID: 15555542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. If artemisinin drugs fail, what's plan B?
    Enserink M
    Science; 2010 May; 328(5980):846. PubMed ID: 20466918
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious diseases. Cracks in the first line of defense.
    Vogel G
    Science; 2005 Dec; 310(5754):1607. PubMed ID: 16339425
    [No Abstract]   [Full Text] [Related]  

  • 12. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Realistically, how far are we from a universal malaria drug?
    Biamonte MA
    Future Med Chem; 2014 Feb; 6(2):123-6. PubMed ID: 24467238
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimalarial chemotherapy: young guns or back to the future?
    Biagini GA; O'Neill PM; Nzila A; Ward SA; Bray PG
    Trends Parasitol; 2003 Nov; 19(11):479-87. PubMed ID: 14580958
    [No Abstract]   [Full Text] [Related]  

  • 15. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin Resistance and the Unique Selection Pressure of a Short-acting Antimalarial.
    Khoury DS; Cao P; Zaloumis SG; Davenport MP;
    Trends Parasitol; 2020 Nov; 36(11):884-887. PubMed ID: 32771284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial activity of artemisinins: identification of a novel target?
    Mercereau-Puijalon O; Fandeur T
    Lancet; 2003 Dec; 362(9401):2035-6. PubMed ID: 14697798
    [No Abstract]   [Full Text] [Related]  

  • 18. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance.
    Chen I; Hsiang MS
    Lancet Infect Dis; 2022 Jun; 22(6):751-753. PubMed ID: 35276063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.